Critical Care Diagnostics Market Size, Share, Analysis, Trends, Growth Report, 2030

Critical Care Diagnostics Market

Critical Care Diagnostics Market by Type (Routine & Special Chemistry, Coagulation Test, Microbial & Infectious Diseases, Immunoproteins, Hematology, Flow Cytometry, and Others), by End Use (Emergency Rooms, Operating Rooms, Icus and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2021 – 2028

Category: Medical Device Report Format : PDF Pages: 155 Report Code: ZMR-6124 Published Date: Sep-2021 Status : Published
Market Size in 2020 Market Forecast in 2026 CAGR (in %) Base Year
USD 1.2 Billion USD 1.9 Billion 6.2% 2020

Critical Care Diagnostics Market

Critical Care Diagnostics Industry Perspective:

The critical care diagnostics market size accounted for USD 1.2 Billion in 2020 and is expected to reach USD 1.9 Billion by 2028, growing at a CAGR of 6.2% from 2021 to 2028.

Critical care is medical care for people with life-threatening illnesses and injuries. Such patients are managed in intensive care units. To stabilize the functioning of the organs and improve patient conditions, advanced diagnostic technology is required for the treatment. Critical care diagnostics plays a vital role in the rapid diagnosis which enables the healthcare provider to take quick and appropriate decisions regarding the treatment of the patients.

COVID-19 Impact Analysis

Due to the COVID-19 pandemic, majorly every industry was shut down for a significant amount of time. The Covid-19 pandemic has put a lot of strain on the healthcare industry as well. The coronavirus has infected millions of people all across the world. The majority of those infected with Covid-19 experienced dyspnoea, necessitating the use of ventilators and hospitalization in the intensive care unit. For these people, a diagnostic test is required. During the Covid-19 pandemic, the worldwide critical care diagnostics market grew at a notable rate, and it is likely to continue growing at a significant rate in the coming years.

Critical Care Diagnostics Market: Growth Factors

There are various factors leading to the growth of the critical care diagnostics market. The growing need for speedy and precise diagnosis, the rise in the incidence of chronic and infectious diseases, and the rise in the elderly population are all factors driving the global market forward. As a result of all of these factors, demand for critical care diagnostics is increasing, fuelling the worldwide critical care diagnostics market's growth. Furthermore, expanding healthcare infrastructure and scientific advancements in critical care diagnostics are two aspects that are propelling the industry forward. Additionally, technological improvements that increase the efficiency and efficacy of diagnostic tests may provide sufficient chances for the worldwide critical care diagnostics market to grow.

Global Critical Care Diagnostics MarketRequest Free Sample

Type Segment Analysis Preview

Due to an increase in demand for speedy and accurate early diagnosis as well as the capacity to minimize patient recovery time, the immunoproteins segment of this market is expected to account for the highest share in terms of value. The need for these diagnostics has increased as patient awareness of better healthcare options has improved and physician expertise in target therapy has improved. Clinical chemistry, flow cytometer testing, and coagulation tests, among other things, are driving the expansion of the entire industry. Microbiology and infectious disease testing, as well as immunoproteins, are expected to fuel segment growth.

End Segment Analysis Preview

Critical care diagnostics are commonly seen in hospital ancillary areas such as emergency rooms, operating rooms, and intensive care units (ICUs), among other places. The market's growth has been affected by the growing acceptance of telemedicine and increased knowledge of improved diagnostics tools. During the projection period, the utilization of emergency rooms in this diagnostics market is likely to boost segment growth.

Critical Care Diagnostics Market: Report Scope

Report Attributes Report Details
Report Name Critical Care Diagnostics Market Research Report
Market Size in 2020 USD 1.2 Billion
Market Forecast in 2028 USD 1.9 Billion
Growth Rate CAGR of 6.2%
Number of Pages 255
Forecast Units Value (USD Billion), and Volume (Units)
Key Companies Covered Abbott Laboratories, Siemens Healthineers, F. Hoffmann-La Roche Ltd., Dickinson and Company, Beckman Coulter, Inc., Alere, Inc., Bayer AG, Bio-Rad Laboratories, Inc., Danaher Corporation, and Chembio Diagnostic Systems, Inc., among others. These companies adopt various strategies in order to boost their presence and capitalization.
Segments Covered By Type, By End Use, And By Region
Regions Covered North America, Europe, Asia Pacific (APAC), Latin America, Middle East and Africa (MEA)
Base Year 2020
Historical Year 2016 to 2020
Forecast Year 2021 - 2028
Customization Scope Avail customized purchase options to meet your exact research needs. Request For Customization

Regional Analysis Preview

The Asia Pacific region is projected to grow at a CAGR of 5.4 % over the forecast period. Asia Pacific is expected to be the fastest-growing region for the critical care diagnostics market. This increase can be attributed to an increase in the number of geriatrics in India, as well as an increase in the number of intensive care specialist hospitals and improved healthcare facilities in many rural areas. Furthermore, the Chinese government's recent health reforms increased patient insurance coverage and strengthened basic healthcare services.

North America is expected to be growing significantly in the critical care diagnostics market. North America is a technologically advanced region, which means the adoption rate of any new technology is very high in the region. The efficiency and efficacy of diagnostic tests may result in ample opportunities for the growth of the market in the region. This is due to an increase in the prevalence of chronic and infectious diseases, technological advancements, and well-established healthcare infrastructure.

Key Market Players & Competitive Landscape

Some of the key players in the critical care diagnostics market are 

  • Abbott Laboratories
  • Siemens Healthineers
  • F. Hoffmann-La Roche Ltd.
  • Dickinson and Company
  • Beckman Coulter. Inc.
  • Alere. Inc.
  • Bayer AG
  • Bio-Rad Laboratories. Inc.
  • Danaher Corporation
  • and Chembio Diagnostic Systems. Inc.
  • among others. 

These companies adopt various strategies in order to boost their presence and capitalization.

The critical care diagnostics market is segmented as follows:   

By Type

  • Routine & Special Chemistry
  • Coagulation Test
  • Microbial & Infectious Diseases
  • Immunoproteins
  • Hematology
  • Flow Cytometry
  • Others

     By End Use

   By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

Methodology

FrequentlyAsked Questions

The critical care diagnostics market size was valued at 1.2 USD Billion in 2020.

 

The critical care diagnostics market size is expected to reach USD 1.9 Billion by 2028, growing at a CAGR of 6.2 % between 2021 to 2028.

Some of the key factors driving the critical care diagnostics market growth are, the rise in the incidence of chronic and infectious diseases, and the rise in the elderly population.

The Asia Pacific region held a substantial share of the market in 2020. The increase in the number of geriatrics population along with government reform is going to contribute significantly towards the growth of the critical care diagnostics market in the region.

Some of the major companies operating in the critical care diagnostics market are Abbott Laboratories, Siemens Healthineers, F. Hoffmann-La Roche Ltd., Dickinson and Company, Beckman Coulter, Inc., Alere, Inc., Bayer AG, Bio-Rad Laboratories, Inc., Danaher Corporation, and Chembio Diagnostic Systems, Inc., among others.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed